Wilson Daniel G.

iRhythm CFO Wilson Daniel G. sold 8,000 shares at $207.44 for $1.7M, reducing holdings by 23.2% to 26.5K shares.

CFO Wilson Daniel G. executed a substantial open-market sale of 8,000 shares at $207.44 on 2025-10-31, reducing his holdings from 34.5K to 26.5K shares (a 23.2% reduction). The stock currently trades at $185.00, down from the $207.44 transaction price. iRhythm is a $6.0B market-cap company experiencing strong revenue growth (+20.1% annually) but remains unprofitable, with a $-5.2M net loss in the latest quarter on $192.9M revenue. The sale represents a discrete reduction in the insider's position rather than a routine rebalancing; however, without a 10b5-1 trading plan FLAG, transaction timing cannot be assessed for pattern significance. The cross-ticker track record shows only 1 prior sell with a 30-day return of +0.4%, and the single measurable prior IRTC trade (a sell on 2025-09-03) also posted +0.4% over 30 days—insufficient data to establish a timing pattern at this ticker.

CFO Wilson Daniel G. sold 5,000 IRTC shares at $175.00 on 2025-09-03; holds 34,470 shares post-transaction.

Wilson Daniel G., serving as Chief Financial Officer, disposed of 5,000 shares (12.7% of pre-transaction holdings) at $175.00 per share for total proceeds of $875,000.00. This sale occurred as iRhythm's stock trades near its 52-week high of $182.17 and has posted strong momentum (+13.6% over 30 days, +24.2% over 90 days), suggesting the transaction did not occur against a backdrop of weakness or price deterioration. The company itself remains unprofitable (net income of $-14.2M in the latest full fiscal year) despite solid revenue growth of +20.1% year-over-year and quarterly revenue of $186.7M, which investors should weigh when evaluating the broader operational trajectory. The sale materially reduces the CFO's direct equity stake in the company while the stock remains near historical highs.